- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04972864
Effects of Respiratory Muscle Training in Patients With Post COVID-19
The coronavirus disease 2019 (COVID-19) outbreak first appeared in Wuhan, China's Hubei Province in December 2019 and has quickly turned into a worldwide pandemic. As of 28 July 2020, 16,465,707 cases of COVID-19 have been reported. COVID-19 is a highly contagious respiratory disease that causes respiratory, physical and psychological dysfunction in patients.
Severe respiratory symptoms have been observed in COVID-19 patients. Fever (88.7%), cough (57.6%) and shortness of breath (45.6%) were observed in an average of 81% of the patients. However, patients with comorbidities such as hypertension and diabetes, usually over 65 years of age, may have very serious pulmonary sequelae of the infection. Due to lung fibrosis as a result of pneumonia in COVID-19, some patients experience severe respiratory failure requiring pulmonary rehabilitation. In the study of Complaints such as peripheral and respiratory muscle weakness, shortness of breath on exertion, and decreased exercise capacity may be seen in patients who have had COVID-19. In addition, while anxiety and depression increase, quality of life may decrease. In a study conducted with geriatric patients who had COVID-19 and were discharged; Peripheral and respiratory muscle strengthening exercises were given to the patient after discharge, and as a result of the study, it was found that the patient's walking distance and cough strength increased, while the complaints of shortness of breath, anxiety and depression decreased significantly. As a result of this; We can say that while shortness of breath, anxiety-depression and complications are reduced with the pulmonary rehabilitation program in patients with pulmonary involvement who have had COVID-19, participation in daily life activities and quality of life increase.
Telerehabilitation is an emerging method that aims to provide rehabilitation to patients and clinicians by reducing barriers such as distance, time and cost by using information and communication technologies. Telerehabilitation enables patients who cannot access rehabilitation due to geographic, economic or physical disabilities to benefit from rehabilitation services. At the same time, the importance of social distance is emphasized for the continuation of the pandemic process and protection from the highly contagious COVID-19 infection.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ankara
-
Çankaya, Ankara, Turkey
- Gazi University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients between the ages of 18-65
- Those with a history of COVID-19 and symptomatic pulmonary distress
- Having an acquaintance who has or knows minimum smartphone or computer usage knowledge
- Being literate
Exclusion Criteria:
- Patients who cannot cooperate with the assessment
- Those who have orthopedic problems or neurological diseases that will affect the evaluation of functional capacity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Exercise training group
Individuals in the treatment group were given respiratory exercises (diaphragmatic breathing, thoracic expansion, exercises to increase chest compliance with respiratory control with exercise band and leg strengthening exercises) and inspiratory muscle training with the Threshold IMT (T-IMT) device.
Inspiratory muscle training was applied for 30 minutes, 3 times a day, 7 days a week for 6 weeks.
|
A regular advanced exercise program was given and followed.
|
|
Placebo Comparator: Control training group
Breathing exercises (diaphragmatic breathing, thoracic expansion, exercises to increase chest compliance with respiratory control with exercise band and leg strengthening exercises) were taught in the control group and only the exercise link containing these exercises was sent.
|
Basic exercises was given at the beginning and did the same exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital Anxiety and Depression Scale
Time Frame: First day
|
A valid and reliable Turkish Hospital Anxiety and Depression Scale (HADS) was used to determine the anxiety and depression levels of the patients.
In the questionnaire consisting of a total of 14 questions, odd-numbered questions assess anxiety and even-numbered questions assess depression.
It has two subgroups, anxiety (HADS-A) and depression (HADS-D).
The lowest score that patients can get from both subgroups is 0, and the highest score is 21.
|
First day
|
|
Functional exercise capacity
Time Frame: First day
|
Functional exercise capacity was evaluated with the 6-minute walk test according to the European Respiratory Society and American Thoracic Society (ATS/ERS) criteria.
Patients were asked to walk as fast as possible at their own walking pace for 6 minutes on a 30-meter straight corridor.
Oxygen saturation and heart rate (Beurer pulse oximeter, Ulm, Germany), respiratory frequency, Respiratory frequency, dyspnea, fatigue and leg fatigue perception (modified Borg scale)were recorded before and after the test and during 1 minute recovery.
|
First day
|
|
30 second sit and stand test
Time Frame: First day
|
It is a test that evaluates the 30 seconds sit-to-stand activity (30 STS), lower extremity strength and dynamic balance of the patient.
The number of times the patient sits and stands in 30 seconds gives the score of the test.
|
First day
|
|
International Physical Activity Questionnaire-short form
Time Frame: First day
|
Physical activity level was evaluated with Turkish valid and reliable International Physical Activity (IPAQ) questionnaire.
The questionnaire consisting of 7 questions gives information about the time spent in walking, moderate-to-vigorous and vigorous activities.
The time spent sitting is considered as a separate question.
A score is obtained in total score metabolic equivalent (MET)-minutes.
According to the result, physical activity level is classified as 'inactive', 'minimally active' and 'very active' .
|
First day
|
|
Numerical Evaluation Scale-Pain
Time Frame: First day
|
The Numeric Rating Scale (NRS) was used to determine the pain level of the patients at rest, activity and at night.
Patients are asked to mark the numbers between 0 and 10 at the time of assessment, in terms of rest, activity and night pain.
|
First day
|
|
Nottingham Health Profile
Time Frame: First day
|
The assessment of quality of life was assessed with the Nottingham Health Profile (NHP).
The questionnaire consists of 38 items and 6 subgroups.
There is a possible score limit for each subgroups, ranging from 0-100.
0 indicates no restrictions, 100 indicates presence of all listed restrictions.
|
First day
|
|
Modified Medical Research Council Dyspnea Scale
Time Frame: First day
|
Assessment of dyspnea was assessed with the Modified Medical Research Council (MMRC) dyspnea scale.
The MMRC is a category scale consisting of 5 statements about dyspnea, scored between 0-4.
|
First day
|
|
Fatigue Severity Scale
Time Frame: First day
|
It was evaluated with the Fatigue Severity Scale (FSS).
It is a scale used by the individual to determine the perception of fatigue.
The scale consists of nine items, each item is scored between 1-7.
An increase in the total score obtained from the scale indicates that the severity of fatigue of the individual increases
|
First day
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 203 (UNIMIB Ethic Commettee)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted
Clinical Trials on Exercise training group
-
Riphah International UniversityCompletedHypertension | ObesePakistan
-
Eastern Mediterranean UniversityCompleted
-
Istanbul University - Cerrahpasa (IUC)CompletedRotator Cuff Tear or Rupture, Not Specified as Traumatic | Pain, ShoulderTurkey
-
Riphah International UniversityCompletedSpinal Cord InjuriesPakistan
-
Gazi UniversityNot yet recruiting
-
Gazi UniversityRecruitingSystemic SclerosisTurkey
-
Gazi UniversityCompletedHematopoietic Stem Cell TransplantationTurkey
-
Federal University of Juiz de ForaCompleted
-
State University of MaringáCompleted
-
Medipol UniversityRecruitingChronic Low Back PainTurkey